Clinical Trial Update: MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing MRD-directed consolidation with Epcor-only or Epcor-R2 after anti-CD19 CAR T-cell therapy for Relapsed/Refractory Large B-cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• Epcor

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Relapsed/Refractory Large B-cell Lymphoma | Phase 2 | Status: RECRUITING